Skip to main content
    U

    Universal Health Services Inc (UHS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $197.81
    +3.74 (+1.92%)

    Market Cap: $11.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Universal Health Services Inc (UHS) Earnings: Report Dates and Results

    Updated Oct 27, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Universal Health Services (UHS) is expected to report earnings on Feb 23, 2027. In the quarter ended Sep 30, 2026, Universal Health Services reported EPS of $5.22, below the $5.31 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    73%(29/40)
    Avg Surprise
    +14.65%

    Upcoming Estimates

    Reports Feb 23, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$5.66
    Range$4.80 - $6.17
    19 analysts
    Revenue Consensus
    $4.79B
    Range$4.55B - $5.09B
    17 analysts
    Reports Apr 26, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$5.62
    Range$4.87 - $6.41
    9 analysts
    EPS Revisions
    0
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$6.02-6.6%
    60d ago$6.00-6.3%
    30d ago$5.92-5.0%
    7d ago$5.60+0.4%
    Current$5.62
    Revenue Consensus
    $4.74B
    Range$4.63B - $4.81B
    9 analysts

    Next Report

    UHS has an expected report date of Feb 23, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 3.7% below the $5.88 reported for the quarter ended Dec 31, 2025.

    UHS Earnings Call

    The latest UHS earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, UHS beat 29, missed 10 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $4.73B, up 5.1% from $4.50B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$5.22$5.31$4.35 - $5.51-1.69%Miss-8.3%152 up, 2 downOct 27, 2026$4.73B
    Jun 30, 2026$5.98$5.66$5.54 - $7.17+5.65%Beat+11.8%121 up, 0 downJul 27, 2026$4.64B
    Mar 31, 2026$5.62$5.46$5.12 - $6.61+2.93%Beat+16.1%121 up, 1 downApr 27, 2026$4.50B
    Dec 31, 2025$5.88$5.88$5.63 - $6.400.00%In line+19.5%141 up, 0 downFeb 25, 2026$4.49B
    Sep 30, 2025$5.69$4.95$4.30 - $5.98+14.95%Beat+53.4%145 up, 0 downOct 27, 2025$4.50B
    Jun 30, 2025$5.35$4.96$4.74 - $5.15+7.86%Beat+24.1%162 up, 1 downJul 28, 2025$4.28B
    Mar 31, 2025$4.84$4.36$4.09 - $4.74+11.01%Beat+30.8%158 up, 2 downApr 28, 2025$4.10B
    Dec 31, 2024$4.92$4.18$3.78 - $4.51+17.84%Beat+57.2%142 up, 0 downFeb 26, 2025$4.11B
    Sep 30, 2024$3.71$3.70$3.38 - $4.09+0.27%Beat+45.5%140 up, 0 downOct 24, 2024$3.96B
    Jun 30, 2024$4.31$3.32$3.14 - $3.53+29.82%Beat+70.4%132 up, 0 downJul 24, 2024$3.91B
    Mar 31, 2024$3.70$3.14$2.89 - $3.45+17.83%Beat+58.1%143 up, 0 downApr 24, 2024$3.84B
    Dec 31, 2023$3.13$2.88$2.70 - $3.10+8.68%Beat+3.6%130 up, 0 downFeb 27, 2024$3.70B
    Sep 30, 2023$2.55$2.36$2.19 - $2.57+8.05%Beat+0.4%140 up, 1 downOct 25, 2023$3.56B
    Jun 30, 2023$2.53$2.42$2.25 - $2.65+4.55%Beat+15.0%141 up, 0 downJul 25, 2023$3.55B
    Mar 31, 2023$2.34$2.19$1.91 - $2.43+6.85%Beat+8.8%170 up, 1 downApr 25, 2023$3.47B
    Dec 31, 2022$3.02$2.96$2.71 - $3.30+2.03%Beat+2.4%150 up, 0 downFeb 27, 2023$3.45B
    Sep 30, 2022$2.54$2.42$2.01 - $2.84+4.96%Beat-4.9%150 up, 1 downOct 25, 2022$3.34B
    Jun 30, 2022$2.20$2.09$2.06 - $3.33+5.26%Beat-41.5%160 up, 1 downJul 25, 2022$3.32B
    Mar 31, 2022$2.15$2.47$2.11 - $2.73-12.96%Miss-11.9%151 up, 0 downApr 25, 2022$3.29B
    Dec 31, 2021$2.95$2.87$2.69 - $3.20+2.79%Beat-17.8%15N/AFeb 24, 2022$3.28B
    Sep 30, 2021$2.67$2.76$2.62 - $2.94-3.26%Miss-7.3%111 up, 0 downOct 25, 2021$3.16B
    Jun 30, 2021$3.76$2.69$2.46 - $2.83+39.78%Beat+28.3%11N/AJul 26, 2021$3.20B
    Mar 31, 2021$2.44$2.24$2.07 - $2.53+8.93%Beat+41.0%11N/AApr 26, 2021$3.01B
    Dec 31, 2020$3.59$2.78$2.62 - $3.10+29.14%Beat+28.7%12N/AFeb 25, 2021$3.09B
    Sep 30, 2020$2.88$1.86$1.53 - $3.09+54.84%Beat+44.7%13N/AOct 29, 2020$2.91B
    Jun 30, 2020$2.93$0.65-$0.32 - $1.77+350.77%Beat+6.2%13N/AJul 27, 2020$2.73B
    Mar 31, 2020$1.73$2.55$1.98 - $2.85-32.16%Miss-29.4%15N/AApr 27, 2020$2.83B
    Dec 31, 2019$2.79$2.57$2.43 - $2.68+8.56%Beat+17.7%15N/AFeb 26, 2020$2.90B
    Sep 30, 2019$1.99$2.30$2.18 - $2.40-13.48%Miss-10.8%16N/AOct 24, 2019$2.82B
    Jun 30, 2019$2.76$2.50$2.34 - $2.60+10.40%Beat+11.7%17N/AJul 25, 2019$2.86B
    Mar 31, 2019$2.45$2.60$2.42 - $2.88-5.77%Miss0.0%18N/AApr 25, 2019$2.80B
    Dec 31, 2018$2.37$2.34$2.21 - $2.48+1.28%Beat+18.5%19N/AFeb 27, 2019$2.75B
    Sep 30, 2018$2.23$2.01$1.86 - $2.13+10.95%Beat+49.7%16N/AOct 25, 2018$2.65B
    Jun 30, 2018$2.47$2.40$2.28 - $2.48+2.92%Beat+27.3%15N/AJul 25, 2018$2.68B
    Mar 31, 2018$2.45$2.59$2.43 - $2.71-5.41%Miss+16.7%16N/AApr 25, 2018$2.69B
    Dec 31, 2017$2.00$1.84$1.72 - $1.94+8.70%Beat+11.1%16N/AFeb 28, 2018$2.64B
    Sep 30, 2017$1.49$1.69$1.58 - $1.75-11.83%Miss-6.9%13N/AOct 25, 2017$2.54B
    Jun 30, 2017$1.94$2.06$2.00 - $2.15-5.83%Miss0.0%12N/AJul 25, 2017$2.61B
    Mar 31, 2017$2.10$2.07N/A+1.45%Beat+6.1%N/AN/AApr 25, 2017$2.61B
    Dec 31, 2016$1.80$1.81N/A-0.55%Miss+5.3%N/AN/AFeb 28, 2017$2.48B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $21.76, up 30.8% from the year before. It was $7.32 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$21.76+30.8%
    Dec 31, 2024$16.64+57.7%
    Dec 31, 2023$10.55+6.5%
    Dec 31, 2022$9.91-16.2%
    Dec 31, 2021$11.82+6.2%
    Dec 31, 2020$11.13+11.4%
    Dec 31, 2019$9.99+4.9%
    Dec 31, 2018$9.52+26.4%
    Dec 31, 2017$7.53+2.9%
    Dec 31, 2016$7.32N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,500 words across 17 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,52017
    2026Q2Jun 30, 20266,23015
    2026Q1Mar 31, 20265,06117
    2025Q4Dec 31, 20257,16918
    2025Q3Sep 30, 20256,82418
    2025Q2Jun 30, 20257,32116
    2025Q1Mar 31, 20256,15817
    2024Q4Dec 31, 20249,04317

    2026Q3 Earnings Call

    Opening remarks

    Darren Lehrich Vice President of Investor Relations Good morning, and welcome to Universal Health Services' third quarter 2026 earnings conference call. I am Darren Lehrich, Vice President of Investor Relations. With me this morning are our President and CEO, Marc Miller, and our Chief Financial Officer, Steve Filton. Marc and Steve will offer some remarks about the quarter, and then we will open up to Q&A. During today's conference call, we will be using words such as believes, expects, anticipates, estimates, and similar words that represent forecast projections and forward-looking statements. For anyone not familiar with the risks and uncertainties inherent in these forward-looking statements, we recommend a careful reading of the section on risk factors and forward-looking statements and risk factors in our Form 10-K for the year ended December 31st, 2025, and in our Form 10-Q for the quarter ended June 30, 2026. In addition, we may reference measures during today's call, such as EBITDA, adjusted EBITDA, adjusted EBITDA net of NCI, and adjusted net income attributable to UHS, which are non-GAAP financial measures. Information and reconciliations of these non-GAAP financial measures to net income attributable to UHS can be found in yesterday's press release and in our supplemental materials on our website. With that, let me now turn it over to Marc for some introductory remarks.

    Marc Miller President and CEO Thank you, Darren. Good morning, and thank you for joining today's call. I will begin with our key takeaways from the quarter, performance relative to our expectations, the principal operating drivers, and progress on our strategic priorities before Steve reviews the detailed financial results and our outlook. Overall, underlying performance in the third quarter reflected sequential improvement in several areas. Acute care demand remained strong, behavioral health volumes demonstrated an increase relative to recent quarters, and labor trends continued to moderate. Expense management remained disciplined overall. Health insurance exchange trends were consistent with our expectations. Steve will provide the reported financial results and segment metrics in his remarks. Third quarter results included certain items that were not reflected in the outlook we provided with our second quarter results in July. These items included the benefit from the expansion of existing Medicaid supplemental programs in several states, partially offset by other non-recurring litigation and transaction costs, which Steve will take you through in a moment. Against that backdrop, I want to highlight three operating and strategic priorities: acute care capacity and outpatient access points, integrating Talkspace, and advancing the recertification process at Laurel Ridge Treatment Center in Texas. First, our recent investments in acute care inpatient capacity helped us meet favorable demand in our markets. The additional 177 beds added during the second quarter are expected to continue ramping through year-end.

    Frequently Asked Questions About UHS

    When is Universal Health Services's next earnings date?

    Universal Health Services's next earnings report is expected for Feb 23, 2027.

    Did UHS beat earnings estimates last quarter?

    No. Universal Health Services reported EPS of $5.22 for the quarter ended Sep 30, 2026, below the $5.31 estimate by 1.69%.

    What EPS do analysts expect from UHS next quarter?

    The consensus EPS estimate for Universal Health Services for the quarter ending Dec 31, 2026 is $5.66 from 19 analysts, with estimates from $4.80 to $6.17.

    How often does UHS beat earnings estimates?

    Universal Health Services beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +7.32%.